CD24 and cancer: By using different parameters to evaluate biomarkers of cancer stemness, such as overexpression of CSC markers, elevated CD44/CD24 ratios, self-renewal capabilities and high invasion potentials, we found that JQ1 can jeopardize stemness in TNBC.